QUART BARRY D sold 51.1% of their position (13.10K shares) of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC on the open market
Open‑market sale worth $656.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/29/2026ACC: 0001384243-26-000010
Director
Since Feb 2026
-13.10K
Net shares
Net seller
$656.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13.10K acquired · 26.20K disposed
Non-Derivative Transactions2
Class A Ordinary Share
Direct
Shares
+13.10K
Price / share
$14.33
Trade value
$187.71K
% of position
104.4%
4/28/2026
12.55K→25.64K
Class A Ordinary Share
Direct
Shares
−13.10K
Price / share
$50.10
Trade value
$656.26K
% of position
51.1%
4/28/2026
25.64K→12.55K
Total
Net shares
+0.00
Net value
-$468.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share Direct | 4/28/2026 | M · Option Exercise | +13.10K | $14.33 | $187.71K | 104.4% | 12.55K | 25.64K |
| Class A Ordinary Share Direct | 4/28/2026 | S · Sale | −13.10K | $50.10 | $656.26K | 51.1% | 25.64K | 12.55K |
| Total | +0.00 | -$468.55K | ||||||
Derivative Transactions1
Share Option
Direct
Converts to
Class A Ordinary Shares
13.10K shares
Shares
−13.10K
Strike price
14.33
Held after
13.24K
Exercisable
—
4/28/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option Direct | Class A Ordinary Shares13.10K shares | 4/28/2026 | M · Option Exercise | −13.10K | 14.33 | — | 13.24K |